Again, we're talking about a facility for doing trial lots, and there's been a dramatic.... Recognizing, as we did and as the Gates Foundation did a few years ago, that at the time there was not capacity for doing trial lots for research purposes, which is one of the steps in terms of developing a new vaccine.... Since that time, academic institutions and others have come to the fore, and this has made that requirement substantially less. There are many other things that require some investment to move this agenda forward, so we will apply it there.
On March 16th, 2010. See this statement in context.